Literature DB >> 15243873

[Psychiatric morbidity in homeless single men].

Birgit Völlm1, Hinnerk Becker, Wilfried Kunstmann.   

Abstract

AIM: The aim of this cross sectional study was to establish the extent of psychiatric morbidity among homeless men and compare this group with a sample of formerly homeless.
METHOD: [corrected] 82 homeless and a comparison group of 37 formerly homeless were interviewed using a psychopathological interview according to AMDP (Arbeitsgemeinschaft für medizinische Dokumentation) as well as selected modules of the CIDI (Composite International Diagnostic Interview). Diagnoses were established according to ICD-10.
RESULTS: The lifetime prevalence of psychiatric disorders was 95.1 %, the current prevalence was 87.8 %. Substance related disorders were the most common group of disorders. In the formerly homeless prevalences were slightly lower.
CONCLUSIONS: Psychiatric morbidity among the homeless is high. Services have to be tailored to meet the needs of this special group. Formerly homeless continue to need intensive psychiatric input.

Entities:  

Mesh:

Year:  2004        PMID: 15243873     DOI: 10.1055/s-2003-815014

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  3 in total

1.  [Threatened homelessness and mental disorders. Prevalence and influencing factors in populations at risk].

Authors:  H J Salize; C Dillmann-Lange; B Kentner-Figura; I Reinhard
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

Review 2.  The Prevalence of Mental Illness in Homeless People in Germany.

Authors:  Stefanie Schreiter; Felix Bermpohl; Michael Krausz; Stefan Leucht; Wulf Rössler; Meryam Schouler-Ocak; Stefan Gutwinski
Journal:  Dtsch Arztebl Int       Date:  2017-10-06       Impact factor: 5.594

Review 3.  The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis.

Authors:  Seena Fazel; Vivek Khosla; Helen Doll; John Geddes
Journal:  PLoS Med       Date:  2008-12-02       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.